Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeNYSE:MRK

      NYSE:MRK

      Merck Stock Went Down Even After the Company Reported Its Q4 Results
      Investing News

      Merck Stock Went Down Even After the Company Reported Its Q4 Results

      February 1, 2023
      Merck Stock Rose After Keytruda Met the Phase 3 Trial Survival Objective in Biliary Tract Cancer
      Investing News

      Merck Stock Rose After Keytruda Met the Phase 3 Trial Survival Objective in Biliary Tract Cancer

      January 25, 2023
      Merck Stock Was Upgraded to Buy at BOFA Despite the Risk Associated With Keytruda
      Trading Tips

      Merck Stock Was Upgraded to Buy at BOFA Despite the Risk Associated With Keytruda

      January 4, 2023
      Merck Stock Flattens as Ranked the Best-performing Major American Pharmaceutical in 2022
      Investing News

      Merck Stock Flattens as Ranked the Best-performing Major American Pharmaceutical in 2022

      December 30, 2022
      Merck Stock Went Up as It Relied on a New Formulation of Keytruda to Avoid a Patent Cliff
      Investing News

      Merck Stock Went Up as It Relied on a New Formulation of Keytruda to Avoid a Patent Cliff

      December 2, 2022
      Merck Stock Is Rallying, Sending a Historically Bullish Signal
      Investing News

      Merck Stock Is Rallying, Sending a Historically Bullish Signal

      November 29, 2022
      Merck Stock Price Rose as the Company Raised Its Full-Year Outlook Due to the Success of Keytruda
      Investing News

      Merck Stock Price Rose as the Company Raised Its Full-Year Outlook Due to the Success of Keytruda

      October 27, 2022
      Merck Beats Expectations for the Third Quarter as Sales of the COVID-19 Tablet Are Partially Offset by Keytruda
      Investing News

      Merck Beats Expectations for the Third Quarter as Sales of the COVID-19 Tablet Are Partially Offset by Keytruda

      October 27, 2022
      Guggenheim Upgraded the Merck Stock to Buy, Noting the Company’s Projected Profits Growth.
      Investing News

      Guggenheim Upgraded the Merck Stock to Buy, Noting the Company’s Projected Profits Growth.

      October 10, 2022
      5 Dow Jones Stocks to Watch in October.
      Investing News

      5 Dow Jones Stocks to Watch in October.

      October 10, 2022
      « 1 2 3 »

       

      LATEST NEWS

      • Investing News Ulta Beauty’s Q3 2025 Earnings Highlight Growth
      • Investing News Beta Technologies Q3 IPO Insights
      • Investing News Salesforce Reports Robust Q3 2026 Earnings
      • Investing News Salesforce’s Stock Boost Amid Raised Guidance
      • Investing News Macy’s Q3 2025 Earnings Overview

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2025